
August 16, 2026
Savannah’s Formosa Bar Launches Tiered Wedding Packages to Simplify Compliance and Planning

August 15, 2026
ESP, LLC Expands Managed IT, Cloud, and VoIP Services Across Catawba and Lincoln Counties

August 15, 2026
Liveops Launches LiveNexus Platform to Blend AI Efficiency with Human Agent Flexibility

August 15, 2026
Ross Voigt’s ‘The Things I Think Sometimes’ Offers Poetic Reflections on Faith, Family, and Life’s Everyday Moments

August 15, 2026
BarnPilot Unveils Watcher and Sentinel to Integrate Horse Monitoring into Its Equestrian Platform

August 15, 2026
Autonomic AI Unveils AssuredCode-C for Real-Time Code Generation in Military and Autonomous Systems

August 15, 2026
Law Bear Auto Accident Attorneys Rebrands to Law Bear Injury Lawyers, Broadening Legal Services in Arizona

August 15, 2026
STR Search Introduces $50K Tax Savings and $5K Happiness Guarantees for Short-Term Rental Acquisitions

August 15, 2026
Slabjack Geotechnical Addresses Hidden Voids Beneath Concrete in Washington and Northern Idaho

August 15, 2026
Memoir Chronicles a Mother’s Decades-Long Fight to Reunite with Abducted Daughter Across Three Continents

August 14, 2026
Vycor Medical Reports Mixed Q2 2026 Results, Highlighting VBAS Clinical Evidence Growth

August 14, 2026
Onco-Innovations Advances ONC010 Toward First-in-Human Trials with Key Manufacturing and Metabolic Studies

August 14, 2026
Regentis Biomaterials Secures Japanese Patent for GelrinC Manufacturing Process, Strengthening Global Cartilage Repair Position

August 14, 2026
Datavault AI to Acquire CyberCatch for $94.5 Million, Integrating AI Cybersecurity into Its Platform

August 14, 2026
Regentis Biomaterials Advances GelrinC as Off-the-Shelf Option in Knee Cartilage Repair Market

August 14, 2026
From Utility Infielder to Community Banker: Matt Kata’s Playbook for Versatility and Leadership

August 14, 2026
Quantum BioPharma Cuts Costs, Advances Multiple Sclerosis Drug to Phase 2 After FDA Approval

August 14, 2026
Regentis Biomaterials Advances GelrinC with Parallel U.S. Clinical and European Commercial Strategies









































